Interest Expense of Semnur Pharmaceuticals, Inc. from 30 Sep 2023 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Semnur Pharmaceuticals, Inc. quarterly and annual Interest Expense in USD history and change rate from 30 Sep 2023 to 30 Jun 2025.
  • Semnur Pharmaceuticals, Inc. Interest Expense for the quarter ending 30 Jun 2025 was $28,345, a 23% increase year-over-year.
  • Semnur Pharmaceuticals, Inc. annual Interest Expense for 2024 was $96,242, a 161% increase from 2023.
Source SEC data
View on sec.gov
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Semnur Pharmaceuticals, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $28,345 +$5,286 +23% 01 Apr 2025 30 Jun 2025 10-Q 15 Aug 2025 2025 Q2
Q1 2025 $26,974 +$5,671 +27% 01 Jan 2025 31 Mar 2025 10-Q 16 May 2025 2025 Q1
Q2 2024 $23,059 01 Apr 2024 30 Jun 2024 10-Q 15 Aug 2025 2025 Q2
Q1 2024 $21,303 01 Jan 2024 31 Mar 2024 10-Q 16 May 2025 2025 Q1
Q3 2023 $100,000 11 Oct 2023 10-K 01 Apr 2024 2023 FY
Q3 2023 $14,738 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3

Semnur Pharmaceuticals, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $96,242 +$59,333 +161% 01 Jan 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
2023 $36,909 01 Jan 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.